Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Mechoulam

Showing results (31-40 of 183) with videos related to

Pageof 19
Sort By:
Biofactors (Oxford, England)|April 23, 2014
N-Acyl amino acids and their impact on biological processesLumír Hanuš, Esther Shohami, Itai Bab, et al.
Plos One|April 16, 2020
Potential combinations of endocannabinoid/endocannabinoid-like compounds and antibiotics against methicillin-resistant Staphylococcus aureusMark Feldman, Reem Smoum, Raphael Mechoulam, et al.
Current Pharmaceutical Design|September 11, 2008
Endocannabinoids in liver disease and hepatic encephalopathyIddo Magen, Yosefa Avraham, Elliot Berry, et al.
Psychopharmacology|September 19, 2003
Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew)Linda A Parker, Magdalena Kwiatkowska, Page Burton, et al.
Psychopharmacology|January 24, 2004
A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew)Magdalena Kwiatkowska, Linda A Parker, Page Burton, et al.
Pharmacology & Toxicology|August 6, 2003
The CB1 cannabinoid receptor agonist, HU-210, reduces levodopa-induced rotations in 6-hydroxydopamine-lesioned ratsYossi Gilgun-Sherki, Eldad Melamed, Raphael Mechoulam, et al.
Clinical Drug Investigation|June 18, 2014
Preliminary, open-label, pilot study of add-on oral Δ9-tetrahydrocannabinol in chronic post-traumatic stress disorderPablo Roitman, Raphael Mechoulam, Rena Cooper-Kazaz, et al.
Stroke|June 28, 2003
Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210Ronen R Leker, Naomi Gai, Raphael Mechoulam, et al.
Microorganisms|March 6, 2021
Anti-Biofilm Activity of Cannabidiol against <i>Candida albicans</i>Mark Feldman, Ronit Vogt Sionov, Raphael Mechoulam, et al.
Investigative Ophthalmology & Visual Science|October 3, 2002
Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoidKrista Laine, Kristiina Järvinen, Raphael Mechoulam, et al.
Pageof 19

Showing results (31-40 of 183) with videos related to

Sort By:
Pageof 19
Biofactors (Oxford, England)|April 23, 2014
N-Acyl amino acids and their impact on biological processesLumír Hanuš, Esther Shohami, Itai Bab, et al.
Plos One|April 16, 2020
Potential combinations of endocannabinoid/endocannabinoid-like compounds and antibiotics against methicillin-resistant Staphylococcus aureusMark Feldman, Reem Smoum, Raphael Mechoulam, et al.
Current Pharmaceutical Design|September 11, 2008
Endocannabinoids in liver disease and hepatic encephalopathyIddo Magen, Yosefa Avraham, Elliot Berry, et al.
Psychopharmacology|September 19, 2003
Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew)Linda A Parker, Magdalena Kwiatkowska, Page Burton, et al.
Psychopharmacology|January 24, 2004
A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew)Magdalena Kwiatkowska, Linda A Parker, Page Burton, et al.
Pharmacology & Toxicology|August 6, 2003
The CB1 cannabinoid receptor agonist, HU-210, reduces levodopa-induced rotations in 6-hydroxydopamine-lesioned ratsYossi Gilgun-Sherki, Eldad Melamed, Raphael Mechoulam, et al.
Clinical Drug Investigation|June 18, 2014
Preliminary, open-label, pilot study of add-on oral Δ9-tetrahydrocannabinol in chronic post-traumatic stress disorderPablo Roitman, Raphael Mechoulam, Rena Cooper-Kazaz, et al.
Stroke|June 28, 2003
Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210Ronen R Leker, Naomi Gai, Raphael Mechoulam, et al.
Microorganisms|March 6, 2021
Anti-Biofilm Activity of Cannabidiol against <i>Candida albicans</i>Mark Feldman, Ronit Vogt Sionov, Raphael Mechoulam, et al.
Investigative Ophthalmology & Visual Science|October 3, 2002
Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoidKrista Laine, Kristiina Järvinen, Raphael Mechoulam, et al.
Pageof 19